Cargando…

Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) has been traditionally perceived as a reproductive disorder due to its most common presentation with menstrual dysfunction and infertility. However, it is now clear that women with PCOS are at increased risk of metabolic dysfunction, from impaired glucose tolerance a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kempegowda, Punith, Melson, Eka, Manolopoulos, Konstantinos N., Arlt, Wiebke, O’Reilly, Michael W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315669/ https://www.ncbi.nlm.nih.gov/pubmed/32637065 http://dx.doi.org/10.1177/2042018820934319

Ejemplares similares

11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome
por: O’Reilly, Michael W., et al.
Publicado: (2016)

AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome
por: O’Reilly, Michael W., et al.
Publicado: (2017)

MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease
por: Schiffer, Lina, et al.
Publicado: (2017)

Concerns and expectations in women with polycystic ovary syndrome vary across age and ethnicity: findings from PCOS Pearls Study
por: Elghobashy, Mirna, et al.
Publicado: (2023)

OR20-01 Machine Learning-based Steroid Metabolome Analysis In Women With Polycystic Ovary Syndrome Reveals Three Distinct Androgen Excess Subtypes With Different Metabolic Risk Profiles.
por: Rocha, Thaís P, et al.
Publicado: (2023)

Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England
por: Subramanian, Anuradhaa, et al.
Publicado: (2022)

Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
por: Kumarendran, Balachandran, et al.
Publicado: (2018)

A systematic review of models of care for polycystic ovary syndrome highlights the gap in the literature, especially in developing countries
por: Melson, Eka, et al.
Publicado: (2023)

A systematic review of lived experiences of people with polycystic ovary syndrome highlights the need for holistic care and co-creation of educational resources
por: Lau, Gar Mun, et al.
Publicado: (2022)

Improving emotional and psychosexual well-being screening in women living with polycystic ovary syndrome: experiences from the United Kingdom and India
por: Hebbar, Meghnaa, et al.
Publicado: (2023)

THU005 Patient And Public Involvement In Virtual Simulation-based Education Informs And Enhances Clinicians’ Knowledge In Managing Polycystic Ovary Syndrome And Adrenal Conditions
por: Pan, Carina S C, et al.
Publicado: (2023)

Appraising Unmet Needs and Misinformation Spread About Polycystic Ovary Syndrome in 85,872 YouTube Comments Over 12 Years: Big Data Infodemiology Study
por: Malhotra, Kashish, et al.
Publicado: (2023)

Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
por: O'Reilly, Michael W., et al.
Publicado: (2014)

Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome
por: Zhang, Bingjie, et al.
Publicado: (2018)

Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies
por: Sanchez-Garrido, Miguel A., et al.
Publicado: (2020)

Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women
por: Elhassan, Yasir S, et al.
Publicado: (2018)

Peripheral blood mononuclear cells preferentially activate 11-oxygenated androgens
por: Schiffer, Lina, et al.
Publicado: (2021)

Incidental finding of lipaemia retinalis on diabetic retinal screening
por: Kempegowda, Punith, et al.
Publicado: (2021)

Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study
por: Subramanian, Anuradhaa, et al.
Publicado: (2021)

SIMBA: using Kolb’s learning theory in simulation-based learning to improve participants’ confidence
por: Davitadze, Meri, et al.
Publicado: (2022)

Diabetic myonecrosis: an uncommon diabetic complication
por: Kempegowda, Punith, et al.
Publicado: (2019)

Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study
por: Kumarendran, Balachandran, et al.
Publicado: (2019)

Adaptation and use of media in an innovative simulation-based clinician training programme
por: Melson, Eka, et al.
Publicado: (2021)

Levelling the learning ground for healthcare professionals across the world through SIMBA: a mixed-methods study
por: Malhotra, Kashish, et al.
Publicado: (2023)

Elevated and diagnostic androgens of polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2020)

Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome
por: Kępczyńska-Nyk, A., et al.
Publicado: (2020)

Androgen Excess Induced Mitochondrial Abnormality in Ovarian Granulosa Cells in a Rat Model of Polycystic Ovary Syndrome
por: Song, Linyi, et al.
Publicado: (2022)

Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome
por: Medeiros, Sebastião Freitas de, et al.
Publicado: (2022)

Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study
por: Kumarendran, Balachandran, et al.
Publicado: (2021)

SAT373 A Systematic Review and Meta-Analysis Show Body Image Concerns Are Significantly Higher in Women and Individuals With Polycystic Ovary Syndrome
por: Kempegowda, Punith, et al.
Publicado: (2023)

Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study
por: Yuan, Chun, et al.
Publicado: (2016)

The interplay between androgens and the immune response in polycystic ovary syndrome
por: Shabbir, Sania, et al.
Publicado: (2023)

The Pancreas Is Altered by In Utero Androgen Exposure: Implications for Clinical Conditions Such as Polycystic Ovary Syndrome (PCOS)
por: Rae, Mick, et al.
Publicado: (2013)

Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
por: McDonnell, Tara, et al.
Publicado: (2022)

SUN-019 Androgens Modulate Lipid Metabolism and Absorption in Control and Polycystic Ovary-Metabolic Syndrome Conditions
por: Vine, Donna Faye, et al.
Publicado: (2020)

Simulation via instant messaging-Birmingham advance (SIMBA) model helped improve clinicians’ confidence to manage cases in diabetes and endocrinology
por: Melson, Eka, et al.
Publicado: (2020)

Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome
por: Han, Qixin, et al.
Publicado: (2021)

Intracrine androgen biosynthesis, metabolism and action revisited
por: Schiffer, Lina, et al.
Publicado: (2018)

Acute Hypercortisolemia Exerts Depot-Specific Effects on Abdominal and Femoral Adipose Tissue Function
por: Manolopoulos, Konstantinos N., et al.
Publicado: (2017)

Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism
por: Zhang, Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aaja1ng0imokefomg7juhi8h0b